These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 20100233)

  • 1. Effects of transgenic endothelin-2 overexpression on diabetic cardiomyopathy in rats.
    Liefeldt L; Rylski B; Walcher F; Manhart J; Kron S; Rosenke YW; Paul M; Neumayer HH; Amann K; Peters H
    Eur J Clin Invest; 2010 Mar; 40(3):203-10. PubMed ID: 20100233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes-induced myocardial structural changes: role of endothelin-1 and its receptors.
    Chen S; Evans T; Mukherjee K; Karmazyn M; Chakrabarti S
    J Mol Cell Cardiol; 2000 Sep; 32(9):1621-9. PubMed ID: 10966825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial overexpression of adenine nucleotide translocase 1 ameliorates diabetic cardiomyopathy in mice.
    Wang Y; Ebermann L; Sterner-Kock A; Wika S; Schultheiss HP; Dörner A; Walther T
    Exp Physiol; 2009 Feb; 94(2):220-7. PubMed ID: 18945756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contributions of endothelin-1 and sodium hydrogen exchanger-1 in the diabetic myocardium.
    Hileeto D; Cukiernik M; Mukherjee S; Evans T; Barbin Y; Downey D; Karmazyn M; Chakrabarti S
    Diabetes Metab Res Rev; 2002; 18(5):386-94. PubMed ID: 12397581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in expression of adrenomedullin in the myocardium of streptozotocin-induced diabetic rats.
    He RX; Gu CL; Shen F; Zhang XM
    Chin Med J (Engl); 2007 Feb; 120(3):187-91. PubMed ID: 17355819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor-alpha antagonism protects from myocardial inflammation and fibrosis in experimental diabetic cardiomyopathy.
    Westermann D; Van Linthout S; Dhayat S; Dhayat N; Schmidt A; Noutsias M; Song XY; Spillmann F; Riad A; Schultheiss HP; Tschöpe C
    Basic Res Cardiol; 2007 Nov; 102(6):500-7. PubMed ID: 17909696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional, structural and molecular aspects of diastolic heart failure in the diabetic (mRen-2)27 rat.
    Connelly KA; Kelly DJ; Zhang Y; Prior DL; Martin J; Cox AJ; Thai K; Feneley MP; Tsoporis J; White KE; Krum H; Gilbert RE
    Cardiovasc Res; 2007 Nov; 76(2):280-91. PubMed ID: 17716638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression for endothelins and their receptors in glomeruli of diabetic rats.
    Fukui M; Nakamura T; Ebihara I; Osada S; Tomino Y; Masaki T; Goto K; Furuichi Y; Koide H
    J Lab Clin Med; 1993 Aug; 122(2):149-56. PubMed ID: 8340699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardioprotective effects of atrasentan, an endothelin-A receptor antagonist, but not of nitric oxide in diabetic mice with myocyte-specific overexpression of endothelial nitric oxide synthase.
    Wölkart G; Stessel H; Saad Z; Kirchengast M; Brunner F
    Br J Pharmacol; 2006 Jul; 148(5):671-81. PubMed ID: 16702986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total triterpene acids, active ingredients from Fructus Corni, attenuate diabetic cardiomyopathy by normalizing ET pathway and expression of FKBP12.6 and SERCA2a in streptozotocin-rats.
    Qi MY; Liu HR; Dai DZ; Li N; Dai Y
    J Pharm Pharmacol; 2008 Dec; 60(12):1687-94. PubMed ID: 19000375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FT011, a new anti-fibrotic drug, attenuates fibrosis and chronic heart failure in experimental diabetic cardiomyopathy.
    Zhang Y; Edgley AJ; Cox AJ; Powell AK; Wang B; Kompa AR; Stapleton DI; Zammit SC; Williams SJ; Krum H; Gilbert RE; Kelly DJ
    Eur J Heart Fail; 2012 May; 14(5):549-62. PubMed ID: 22417655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced MMP-2 activity contributes to cardiac fibrosis in experimental diabetic cardiomyopathy.
    Van Linthout S; Seeland U; Riad A; Eckhardt O; Hohl M; Dhayat N; Richter U; Fischer JW; Böhm M; Pauschinger M; Schultheiss HP; Tschöpe C
    Basic Res Cardiol; 2008 Jul; 103(4):319-27. PubMed ID: 18347835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuation by metallothionein of early cardiac cell death via suppression of mitochondrial oxidative stress results in a prevention of diabetic cardiomyopathy.
    Cai L; Wang Y; Zhou G; Chen T; Song Y; Li X; Kang YJ
    J Am Coll Cardiol; 2006 Oct; 48(8):1688-97. PubMed ID: 17045908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrovascular disease of coronaries and cerebral arteries in streptozotocin-induced diabetic rats. A controlled, comparative study.
    Mavrikakis ME; Sfikakis PP; Kontoyannis D; Horti M; Kittas C; Koutras DA; Raptis SA
    Exp Clin Endocrinol Diabetes; 1998; 106(1):35-40. PubMed ID: 9516057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of systemic insulin and angiotensin II receptor subtype-1 antagonist on endothelin-1 receptor subtype(s) regulation and binding in diabetic rat heart.
    Karam CN; Nuwayri-Salti N; Usta JA; Zwainy DS; Abrahamian RE; Al Jaroudi WA; Baasisri MJ; Abdallah SM; Bitar KM; Bikhazi AB
    Endothelium; 2005; 12(5-6):225-31. PubMed ID: 16410221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelin antagonism normalizes VEGF signaling and cardiac function in STZ-induced diabetic rat hearts.
    Jesmin S; Zaedi S; Shimojo N; Iemitsu M; Masuzawa K; Yamaguchi N; Mowa CN; Maeda S; Hattori Y; Miyauchi T
    Am J Physiol Endocrinol Metab; 2007 Apr; 292(4):E1030-40. PubMed ID: 17148754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metallothionein suppresses angiotensin II-induced nicotinamide adenine dinucleotide phosphate oxidase activation, nitrosative stress, apoptosis, and pathological remodeling in the diabetic heart.
    Zhou G; Li X; Hein DW; Xiang X; Marshall JP; Prabhu SD; Cai L
    J Am Coll Cardiol; 2008 Aug; 52(8):655-66. PubMed ID: 18702970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the sodium hydrogen exchanger-1 in mediating diabetes-induced changes in the retina.
    Cukiernik M; Hileeto D; Downey D; Evans T; Khan ZA; Karmazyn M; Chakrabarti S
    Diabetes Metab Res Rev; 2004; 20(1):61-71. PubMed ID: 14737747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial hypertrophy and enhanced left ventricular contractility in Zucker diabetic fatty rats.
    Fredersdorf S; Thumann C; Ulucan C; Griese DP; Luchner A; Riegger GA; Kromer EP; Weil J
    Cardiovasc Pathol; 2004; 13(1):11-9. PubMed ID: 14761780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetic endothelin B receptor-deficient rats develop severe hypertension and progressive renal failure.
    Pfab T; Thöne-Reineke C; Theilig F; Lange I; Witt H; Maser-Gluth C; Bader M; Stasch JP; Ruiz P; Bachmann S; Yanagisawa M; Hocher B
    J Am Soc Nephrol; 2006 Apr; 17(4):1082-9. PubMed ID: 16495378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.